Top experts from Amgen, CBIZ & Intrepid discuss 2025 trends in healthcare, biotech, and life sciences. Explore key insights ...

Gene editing may hold the key to rescuing endangered species—not just by preserving them, but by restoring their lost genetic ...

Philadelphia, PA, July 21, 2025 - NodThera, a leading clinical-stage biotech delivering a paradigm shift in the treatment of ...

Icotrokinra is a first-in-class investigational targeted oral peptide that selectively blocks the IL-23 receptor Filing based on unprecedented data package that met all primary endpoints across four ...

PROTEUS, a system designed to harness “directed evolution,” can speed the process up by years, or even decades.

The landscape of cancer therapeutics is rapidly evolving with the emergence of sophisticated biologics designed to deliver highly targeted and potent ...

Kaizen Biosciences, Co., a Philadelphia-based biopharmaceutical firm, is making strides toward regulatory approval for its novel pediatric antibiotic formulation, following the acceptance of new ...